Effect of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide on mouse preantral follicle development in vitro. 2004

Sandra Cecconi, and Gianna Rossi, and Marzia Barberi, and Lucia Scaldaferri, and Rita Canipari
Department of Biomedical Sciences and Technologies, Faculty of Medicine, University of L'Aquila, Italy.

Pituitary adenylate cyclase-activating polypeptide (PACAP) is a bioactive peptide isolated from ovine hypothalamus. It is transiently expressed in preovulatory follicles and positively affects several parameters correlated with the ovulatory process. It has also been shown to be expressed in the interstitial tissue around primordial and preantral follicles. The aim of the present study was to investigate whether PACAP influences preantral follicle growth and differentiation. Mouse preantral follicles were cultured for 5 d in the presence of FSH and increasing concentrations of PACAP or vasoactive intestinal polypeptide (VIP) (10(-12) to 10(-7) m). In the presence of FSH, follicles increased in diameter and formed an antrum. At the concentrations tested, neither PACAP alone nor VIP alone had any effect on follicle development, but the addition of either peptide to FSH-stimulated follicles caused a dose-dependent inhibition of follicle growth, antrum formation, granulosa cell proliferation, and estradiol production. The effect of PACAP on follicle growth and antrum formation was directly correlated with the length of stimulation and was reversible. Although exposure of follicles to 10(-7) m PACAP and VIP did not affect oocyte growth, it severely impaired completion of meiotic maturation in oocytes isolated from the follicles and cultured for 17 h in medium alone. The cyclic production of PACAP by preovulatory follicles during the estrous cycle in adult rats and its induction by LH in the rat and mouse ovary suggest that this peptide may play a role in the local regulation of preantral follicle growth.

UI MeSH Term Description Entries
D008540 Meiosis A type of CELL NUCLEUS division, occurring during maturation of the GERM CELLS. Two successive cell nucleus divisions following a single chromosome duplication (S PHASE) result in daughter cells with half the number of CHROMOSOMES as the parent cells. M Phase, Meiotic,Meiotic M Phase,M Phases, Meiotic,Meioses,Meiotic M Phases,Phase, Meiotic M,Phases, Meiotic M
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D009479 Neuropeptides Peptides released by NEURONS as intercellular messengers. Many neuropeptides are also hormones released by non-neuronal cells. Neuropeptide
D009865 Oocytes Female germ cells derived from OOGONIA and termed OOCYTES when they enter MEIOSIS. The primary oocytes begin meiosis but are arrested at the diplotene state until OVULATION at PUBERTY to give rise to haploid secondary oocytes or ova (OVUM). Ovocytes,Oocyte,Ovocyte
D011979 Receptors, Pituitary Hormone Cell surface proteins that bind pituitary hormones with high affinity and trigger intracellular changes influencing the behavior of cells. Since many pituitary hormones are also released by neurons as neurotransmitters, these receptors are also found in the nervous system. Pituitary Hormone Receptors,Receptors, Pituitary Hormones,Pituitary Hormones Receptors
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005260 Female Females
D005640 Follicle Stimulating Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity. FSH (Follicle Stimulating Hormone),Follicle-Stimulating Hormone,Follitropin

Related Publications

Sandra Cecconi, and Gianna Rossi, and Marzia Barberi, and Lucia Scaldaferri, and Rita Canipari
October 1995, British journal of pharmacology,
Sandra Cecconi, and Gianna Rossi, and Marzia Barberi, and Lucia Scaldaferri, and Rita Canipari
March 1996, The Journal of endocrinology,
Sandra Cecconi, and Gianna Rossi, and Marzia Barberi, and Lucia Scaldaferri, and Rita Canipari
February 2016, Current opinion in endocrinology, diabetes, and obesity,
Sandra Cecconi, and Gianna Rossi, and Marzia Barberi, and Lucia Scaldaferri, and Rita Canipari
February 1996, Endocrine reviews,
Sandra Cecconi, and Gianna Rossi, and Marzia Barberi, and Lucia Scaldaferri, and Rita Canipari
April 1997, Journal of neuroendocrinology,
Sandra Cecconi, and Gianna Rossi, and Marzia Barberi, and Lucia Scaldaferri, and Rita Canipari
August 1991, Neuroendocrinology,
Sandra Cecconi, and Gianna Rossi, and Marzia Barberi, and Lucia Scaldaferri, and Rita Canipari
December 1998, Annals of the New York Academy of Sciences,
Sandra Cecconi, and Gianna Rossi, and Marzia Barberi, and Lucia Scaldaferri, and Rita Canipari
October 1997, Neuropeptides,
Sandra Cecconi, and Gianna Rossi, and Marzia Barberi, and Lucia Scaldaferri, and Rita Canipari
February 1994, British journal of pharmacology,
Sandra Cecconi, and Gianna Rossi, and Marzia Barberi, and Lucia Scaldaferri, and Rita Canipari
October 1992, Trends in endocrinology and metabolism: TEM,
Copied contents to your clipboard!